328 related articles for article (PubMed ID: 18952043)
21. Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors.
Tug S; Delos Reyes B; Fandrey J; Berchner-Pfannschmidt U
Biochem Biophys Res Commun; 2009 Jul; 384(4):519-23. PubMed ID: 19427832
[TBL] [Abstract][Full Text] [Related]
22. The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3.
Jaakkola PM; Rantanen K
Biol Chem; 2013 Apr; 394(4):449-57. PubMed ID: 23380539
[TBL] [Abstract][Full Text] [Related]
23. Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.
Tarhonskaya H; Hardy AP; Howe EA; Loik ND; Kramer HB; McCullagh JS; Schofield CJ; Flashman E
J Biol Chem; 2015 Aug; 290(32):19726-42. PubMed ID: 26112411
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a stereoelectronic effect in human oxygen sensing.
Loenarz C; Mecinović J; Chowdhury R; McNeill LA; Flashman E; Schofield CJ
Angew Chem Int Ed Engl; 2009; 48(10):1784-7. PubMed ID: 19180614
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
[TBL] [Abstract][Full Text] [Related]
26. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro.
Pan Y; Mansfield KD; Bertozzi CC; Rudenko V; Chan DA; Giaccia AJ; Simon MC
Mol Cell Biol; 2007 Feb; 27(3):912-25. PubMed ID: 17101781
[TBL] [Abstract][Full Text] [Related]
27. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.
Percy MJ; Furlow PW; Beer PA; Lappin TR; McMullin MF; Lee FS
Blood; 2007 Sep; 110(6):2193-6. PubMed ID: 17579185
[TBL] [Abstract][Full Text] [Related]
28. Determination and modulation of prolyl-4-hydroxylase domain oxygen sensor activity.
Wirthner R; Balamurugan K; Stiehl DP; Barth S; Spielmann P; Oehme F; Flamme I; Katschinski DM; Wenger RH; Camenisch G
Methods Enzymol; 2007; 435():43-60. PubMed ID: 17998048
[TBL] [Abstract][Full Text] [Related]
29. Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay.
Ehrismann D; Flashman E; Genn DN; Mathioudakis N; Hewitson KS; Ratcliffe PJ; Schofield CJ
Biochem J; 2007 Jan; 401(1):227-34. PubMed ID: 16952279
[TBL] [Abstract][Full Text] [Related]
30. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
Masson N; Ratcliffe PJ
J Cell Sci; 2003 Aug; 116(Pt 15):3041-9. PubMed ID: 12829734
[TBL] [Abstract][Full Text] [Related]
31. Regulation of HIF: prolyl hydroxylases.
Stolze IP; Mole DR; Ratcliffe PJ
Novartis Found Symp; 2006; 272():15-25; discussion 25-36. PubMed ID: 16686427
[TBL] [Abstract][Full Text] [Related]
32. Role of iron (II)-2-oxoglutarate-dependent dioxygenases in the generation of hypoxia-induced phosphatidic acid through HIF-1/2 and von Hippel-Lindau-independent mechanisms.
Martín-Puig S; Temes E; Olmos G; Jones DR; Aragonés J; Landázuri MO
J Biol Chem; 2004 Mar; 279(10):9504-11. PubMed ID: 14681229
[TBL] [Abstract][Full Text] [Related]
33. Substrate preference of the HIF-prolyl hydroxylase-2 (PHD2) and substrate-induced conformational change.
Pektas S; Knapp MJ
J Inorg Biochem; 2013 Sep; 126():55-60. PubMed ID: 23787140
[TBL] [Abstract][Full Text] [Related]
34. Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
Yeoh KK; Chan MC; Thalhammer A; Demetriades M; Chowdhury R; Tian YM; Stolze I; McNeill LA; Lee MK; Woon ECY; Mackeen MM; Kawamura A; Ratcliffe PJ; Mecinović J; Schofield CJ
Org Biomol Chem; 2013 Feb; 11(5):732-745. PubMed ID: 23151668
[TBL] [Abstract][Full Text] [Related]
35. Hinokitiol activates the hypoxia-inducible factor (HIF) pathway through inhibition of HIF hydroxylases.
Lee MJ; Kim JW; Yang EG
Biochem Biophys Res Commun; 2010 May; 396(2):370-5. PubMed ID: 20416277
[TBL] [Abstract][Full Text] [Related]
36. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ
IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592
[TBL] [Abstract][Full Text] [Related]
37. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.
Barth S; Nesper J; Hasgall PA; Wirthner R; Nytko KJ; Edlich F; Katschinski DM; Stiehl DP; Wenger RH; Camenisch G
Mol Cell Biol; 2007 May; 27(10):3758-68. PubMed ID: 17353276
[TBL] [Abstract][Full Text] [Related]
38. HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
[TBL] [Abstract][Full Text] [Related]
39. Prolyl hydroxylases and therapeutics.
Smith TG; Talbot NP
Antioxid Redox Signal; 2010 Apr; 12(4):431-3. PubMed ID: 19761407
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.
Kwon HS; Choi YK; Kim JW; Park YK; Yang EG; Ahn DR
Bioorg Med Chem Lett; 2011 Jul; 21(14):4325-8. PubMed ID: 21665470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]